[EN] NOVEL [N-ME-4-HYDROXYLEUCINE]-9-CYCLOSPORIN ANALOGUES<br/>[FR] NOUVEAUX ANALOGUES DE [N-ME-4-HYDROXYLEUCINE]-9-CYCLOSPORINE
申请人:ENANTA PHARM INC
公开号:WO2014085623A1
公开(公告)日:2014-06-05
The present invention relates to novel cyclosporine analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.